
Potential Hidden Small-Cap Gem Still Flying Under The Radar
Only a few analysts are following this strongly profitable small-cap stock.
Only a few analysts are following this strongly profitable small-cap stock.
Come ask a question if you want!
The tariffs brought in by the Trump administration are causing havoc on the stock market. What to do?
The H1 FY 2025 results were boring but decent. The sprawling empire brings risk, but the business still looks solid.
A new podcast covering the latest ASX small-cap investing news, with regular deep dives on ASX growth stocks.
Southern Cross Electrical Engineering (ASX: SXE) today announced the acquisition of Fire Force. Chris Coe takes a look at this long term holding of his.
Mayfield Group (ASX: MYG) lands major contracts and grows revenue. Could this overlooked infrastructure stock be a long-term winner?
Polynovo has a great product, but the company has too much leadership turmoil for my taste.
Acusensus (ASX: ACE) is leading road rule enforcement company. The revenue growth is attractive but I hesitate over a few key risks.
Vysarn (ASX: VYS) has a lot of moving parts, and not all are growing.
The company is still growing revenue but free cash flow generation and profit margins are tracking below expectations.
Markets have entered “risk off” mode, I think there is good reason for it.
3 reasons I will sell my shares in AF Legal after considering the half-year report.
Dicker Data (ASX: DDR) showed a strong profitability improvement in the second half of its CY 2024 reporting year.
Monash IVF (ASX: MVF) shifts from acquisitions to organic growth, eyeing Victoria’s recovery, global expansion, and cost efficiencies to drive future gains.
The KME H1 FY 2025 results showed modest revenue growth, improved profit, and a strengthening balance sheet.
Doctors love Polynovo’s Novosorb BTM and Novosorb MTX products, but the market hated its H1 FY 2025 results.
IPD Group (ASX: IPG) reported decent results and the IPD Group share price has moved up slightly, despite weak commercial construction.
Growth Gauge has long followed Audinate shares, and is expecting more optimism in the future, after the undeniably tough H1 FY 2025 results were released.